Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

Share Price is delayed by 15 minutes
Get Live Data
325.00    0.00 (0.00%)
Bid:
310.00
Ask:
340.00
Spread: 30.00 (9.677%)
Market Cap: £8.24m
HSM Live PriceLast checked at - London Stock Exchange

Intraday Samuel Heath Share Chart

Half-year Report

12 Nov 2020 07:00

RNS Number : 0488F
Heath(Samuel) & Sons PLC
12 November 2020
Β 

SAMUEL HEATH & SONS plc

("the Company")

Β 

INTERIM REPORT

Β 

Half year ended 30 September 2020

Β 

CHAIRMAN'S STATEMENT

Β 

Β 

This has been the most extraordinary half year in my rather lengthy business career. Regrettably there is still not yet a clear outcome by any means.

Β 

Our trading performance for the six months until September 30th was quite a lot better than feared but still only produced a small profit of Β£6k before exceptional items (2019: Β£363k), on sales of Β£4.850m (2019: Β£6.920m). As I mentioned in my annual report, without any doubt this was greatly aided by the Government's furlough scheme. This was imaginative and effective. It helped us on all sides of the business, but particularly on the sales side. However, as it was coming to an end, we had to make some difficult decisions to protect the future of the Company. This resulted in considerable redundancy payments, shown in the accounts as exceptional. This brought our total half year results to a loss of Β£224k before taxation (2019: profit Β£363k).

Β 

You cannot run a business like ours successfully for long without a considerable sales team, focussed marketing activities and continual research and development. We have therefore brought these back into play for the second half of the year. This is clearly not without risk.

Β 

There are differing views on the next six months. We have the U.S. election which could affect a manufacturer at the luxury end of the market, the unknown outcome of the talks with the EU, and, by far the worst of all, the return in volume of the Coronavirus. Anybody offering a forecast in these circumstances would be extremely unwise.

Β 

This leaves the question of the dividend. Apart from the ethical question of whether we should pay out dividends when in receipt of Government money, notwithstanding the millions we have paid over the years in taxes, there is more importantly the possible cash requirements of the Company over the next six months. We have therefore decided not to pay an interim dividend but hope to return to normality next year.

Β 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Β 

Sam Heath

Chairman

11 November 2020

Β 

For further information, please contact:

Samuel Heath & Sons Plc

Simon Latham, Company Secretary 0121 766 4200

Β 

Cairn Financial Advisers LLP

James Caithie / Jo Turner 020 7213 0880

Β 

Unaudited Interim Financial Report

For the Half Year ended 30 September 2020

Β 

CONSOLIDATED INCOME STATEMENT

Β 

Β 

Β 

Β 

Β 

Β 

Half year

Β 

Half year

Β 

Year

Β 

ended 30

Β 

ended 30

Β 

ended 31

Β 

September

Β 

September

Β 

March

Β 

2020

Β 

2019

Β 

2020

Β 

Unaudited

Β 

Unaudited

Β 

Audited

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

Revenue

4,850

Β 

6,920

Β 

13,887

Β 

Β 

Β 

Β 

Β 

Β 

Cost of sales

(3,062)

Β 

(3,598)

Β 

(6,798)

Β 

Β 

Β 

Β 

Β 

Β 

Gross profit

1,788

Β 

3,322

Β 

7,089

Β 

Β 

Β 

Β 

Β 

Β 

Selling and distribution costs

(1,344)

Β 

(1,776)

Β 

(3,543)

Administrative expenses

(940)

Β 

(1,067)

Β 

(2,012)

Other operating income - grant (note 6)

596

Β 

-

Β 

-

Β 

Β 

Β 

Β 

Β 

Β 

Operating profit

100

Β 

479

Β 

1,534

Β 

Β 

Β 

Β 

Β 

Β 

Finance income

14

Β 

Β 9

Β 

25

Finance cost

(108)

Β 

(125)

Β 

(191)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Profit before taxation and exceptional items

Β 

6

Β 

363

Β 

1,368

Β 

Β 

Β 

Β 

Β 

Β 

Exceptional item (note 5)

(230)

Β 

-

Β 

-

Β 

Β 

Β 

Β 

Β 

Β 

(Loss)/profit before taxation

(224)

Β 

363

Β 

1,368

Β 

Β 

Β 

Β 

Β 

Β 

Taxation

43

Β 

(69)

Β 

(299)

Β 

Β 

Β 

Β 

Β 

Β 

(Loss)/profit for the period

(181)

Β 

294

Β 

1,069

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Basic and diluted (loss)/earnings per ordinary share (note 4)

(7.1p)

Β 

11.6p

Β 

42.2p

Β 

Β 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Half year ended 30 September

Β 

Half year ended 30 September

Β 

Year ended 31 March

Β 

Β 

2020

Β 

2019

Β 

2020

Β 

Unaudited

Β 

Unaudited

Β 

Audited

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Β 

Β 

Β 

Β 

Β 

Β 

(Loss)/profit for the period

(181)Β 

Β 

294

Β 

1,069

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Items that will not be reclassified to profit or loss:

Β 

Β 

Β 

Β 

Β 

Actuarial gain/(loss) on defined benefit pension scheme

(1,239)

Β 

Β 204

Β 

291

Deferred tax on actuarial loss/(gain)

218

Β 

(34)

Β 

(55)

Deferred tax rate change

-

Β 

-

Β 

125

Revaluation of property, plant and equipment

-

Β 

-

Β 

182

Deferred taxation on revaluation of assets

-

Β 

-

Β 

(23)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(1,021)

Β 

170

Β 

520

Β 

Β 

Β 

Β 

Β 

Β 

Total comprehensive income for the period

(1,202)

Β 

464

Β 

1,589

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION

Β 

At 30 September

Β 

Β At 30 September

Β 

At 31 March

Β 

Β 

2020

Β 

2019

Β 

2020

Β 

Β 

Unaudited

Β 

Unaudited

Β 

Audited

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Non-current assets

Β 

Β 

Β 

Β 

Β 

Intangible assets

135

Β 

74

Β 

151

Property, plant and equipment

3,541

Β 

3,519

Β 

3,635

Deferred tax assets

1,103

Β 

972

Β 

887

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4,779

Β 

4,565

Β 

4,673

Β 

Β 

Β 

Β 

Β 

Β 

Current assets

Β 

Β 

Β 

Β 

Β 

Inventories

3,869

Β 

3,883

Β 

4,230

Trade and other receivables

1,689

Β 

2,216

Β 

2,370

Cash and cash equivalents

3,424

Β 

3,100

Β 

3,016

Β 

8,982

Β 

9,199

Β 

9,616

Β 

Β 

Β 

Β 

Β 

Β 

Total assets

13,761

Β 

13,764

Β 

14,289

Β 

Β 

Β 

Β 

Β 

Β 

Current liabilities

Β 

Β 

Β 

Β 

Β 

Trade and other payables

(1,772)

Β 

(1,665)

Β 

(1,868)

Right of use lease liabilities

(53)

Β 

(57)

Β 

(58)

Current tax payable

(36)

Β 

(239)

Β 

(79)

Β 

(1,861)

Β 

(1,961)

Β 

(2,005)

Β 

Β 

Β 

Β 

Β 

Β 

Non-current liabilities

Β 

Β 

Β 

Β 

Β 

Right of use lease liabilities

(26)

Β 

(75)

Β 

(46)

Retirement benefit scheme

(7,413)

Β 

(7,050)

Β 

(6,575)

Β 

(7,439)

Β 

(7,125)

Β 

(6,621)

Β 

Β 

Β 

Β 

Β 

Β 

Total liabilities

(9,300)

Β 

(9,086)

Β 

(8,626)

Β 

Β 

Β 

Β 

Β 

Β 

Net assets

4,461

Β 

4,678

Β 

5,663

Β 

Β 

Β 

Β 

Β 

Β 

Equity

Β 

Β 

Β 

Β 

Β 

Called up share capital

254

Β 

254

Β 

254

Capital redemption reserve

109

Β 

109

Β 

109

Revaluation reserve

Retained earnings

1,308

2,790

Β 

1,224

3,091

Β 

1,349

3,951

Β 

Β 

Β 

Β 

Β 

Β 

Equity shareholders' funds

4,461

Β 

4,678

Β 

5,663

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β Β Β Β Β Β Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

Β 

Β 

Β 

Share capital

Capital redemption reserve

Revaluation reserve

Retained earnings

Total equity

Β 

Β£000

Β£000

Β£000

Β£000

Β£000

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 31 March 2019

254

109

1,277

2,748

4,388

Β 

Total transactions with owners

Β 

Β 

Β 

Β 

Β 

Equity dividends paid

-

-

-

(174)

Β (174)

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

294

294

Other comprehensive income for the period

Reclassification of depreciation on revaluation

Β 

-

Β 

-

-

Β 

-

-

Β 

(53)

170

Β 

53

170

Β 

-

Total comprehensive income for the period

-

-

(53)

517

464

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 September 2019

254

109

1,224

3,091

4,678

Β 

Total transactions with owners

Β 

Β 

Β 

Β 

Β 

Equity dividends paid

-

-

-

(140)

(140)

Β 

Β 

Β 

Β 

Β 

Β 

Profit for the period

-

-

-

775

775

Other comprehensive income for the period

Reclassification of depreciation on revaluation

Β 

-

Β 

-

-

Β 

-

159

Β 

(34)

191

Β 

34

350

Β 

-

Total comprehensive income for the period

-

-

125

1,000

1,125

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 31 March 2020

254

109

1,349

3,951

5,663

Β 

Β 

Β 

Β 

Β 

Β 

Total transactions with owners

Equity dividends paid

-

-

-

-

-

Β 

Β 

Β 

Β 

Β 

Β 

Loss for the period

-

-

-

(181)

(181)

Other comprehensive income for the period

Reclassification of depreciation on revaluation

Β 

-

Β 

-

-

Β 

-

-

Β 

(41)

(1,021)

Β 

41

(1,021)

Β 

-

Total comprehensive income for the period

-

-

(41)

(1,161)

(1,202)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Balance at 30 September 2020

254

109

1,308

2,790

4,461

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CONSOLIDATED CASH FLOW STATEMENT

Β 

Β 

Half year ended 30 September

Β 

Half year ended 30 September

Β 

Year ended 31 March

Β 

2020

Β 

2019

Β 

2020

Β 

Unaudited

Β 

Unaudited

Β 

Audited

Β 

Β£'000

Β 

Β£'000

Β 

Β£'000

Cash flow from operating activities

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(Loss)/profit for the period before taxation

(224)

Β 

363

Β 

1,368

Β 

Β 

Β 

Β 

Β 

Β 

Adjustments for:

Β 

Β 

Β 

Β 

Β 

Depreciation

155

Β 

192

Β 

405

Amortisation

16

Β 

8

Β 

16

Loss/(profit) on disposal of property, plant and equipment

-

Β 

3

Β 

(3)

Net finance cost/(income)

(14)

Β 

7

Β 

(25)

Defined benefit pension scheme expenses

98

Β 

137

Β 

228

Contributions to defined benefit pension scheme

(500)

Β 

(266)

Β 

(783)

Β 

Β 

Β 

Β 

Β 

Β 

Operating cash flow before movements in working capital

(469)

Β 

444

Β 

1,206

Β 

Β 

Β 

Β 

Β 

Β 

Changes in working capital:

Β 

Β 

Β 

Β 

Β 

Decrease/(increase) in inventories

361

Β 

Β 106

Β 

(241)

Decrease/(increase) in trade and other receivables

658

Β 

46

Β 

(84)

(Decrease)/increase in trade and other payables

(65)

Β 

23

Β 

79

Β 

Β 

Β 

Β 

Β 

Β 

Cash generated from operations

485

Β 

619

Β 

960

Β 

Β 

Β 

Β 

Β 

Β 

Taxation paid

-

Β 

-

Β 

(180)

Β 

Β 

Β 

Β 

Β 

Β 

Net cash from operating activities

485

Β 

619

Β 

780

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from investing activities

Β 

Β 

Β 

Β 

Β 

Payments to acquire property, plant and equipment

(61)

Β 

(510)

Β 

(502)

Proceeds from the sale of property, plant and equipment

-

Β 

19

Β 

14

Payments to acquire intangible assets

-

Β 

-

Β 

(85)

Net finance income

14

Β 

(5)

Β 

25

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(47)

Β 

(496)

Β 

(548)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Cash flow from financing activities

Β 

Β 

Β 

Β 

Β 

Payment for right of use assets

(30)

Β 

(2)

Β 

(55)

Dividends paid

-

Β 

(174)

Β 

(314)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(30)

Β 

(176)

Β 

(369)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Net increase in cash and cash equivalents

408

Β 

(53)

Β 

(137)Β 

Cash and cash equivalents at beginning of period

3,016

Β 

3,153

Β 

3,153

Β 

Β 

Β 

Β 

Β 

Β 

Cash and cash equivalents at end of period

3,424

Β 

3,100

Β 

3,016

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

NOTES TO THE INTERIM FINANCIAL REPORT

Β 

Β 

1. BASIS OF PREPARATION OF INTERIM REPORT

As permitted, IAS34 'Interim Financial Reporting' has not been applied in this interim report. The information for the period ended 30 September 2020 is not audited and does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 March 2020 were given an unqualified audit report and did not contain statements under section 498(2) or 498(3) of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The interim accounts for the half year ended 30 September 2019 were also unaudited.

2. ACCOUNTING POLICIES

Basis of accounting

The report has been prepared on a going concern basis in accordance with International Financial Reporting Standards and interpretations issued by the International Financial Reporting Interpretations Committee as adopted by the European Union.

Β 

The group has not availed itself of early adoption options in standards and interpretations.

Β 

The principal accounting policies adopted are as set out in the Annual Report for the year ended 31 March 2020. The valuation of inventories is considered to be the main area in terms of significant accounting estimates and judgements.

The retirement benefit scheme liability recognised in these interim accounts reflects the estimated change in the deficit at 30 September 2020 from the movements in discount rates and inflation during the six months.

3. DIVIDENDS

Β 

No Interim dividend is proposed (paid 20 March 2020: 5.5p).

4. (LOSS)/EARNINGS PER SHAREΒ 

The basic and diluted (loss)/earnings per share are calculated by dividing the relevant loss after taxation of Β£181,000 (30 September 2019: profit Β£294,000) by the average number of ordinary shares in issue during the period being 2,534,322 (2019: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

5. EXCEPTIONAL ITEM

The exceptional item for the 6 months to 30 September 2020 relates to restructuring costs within the business.

6. OTHER OPERATING INCOME - GRANT FUNDING

Income has been received from government grants providing support during the Coronavirus pandemic:

JRS Β£571,000

Borough Hammersmith & Fulham Β£ 25,000

Β 

Income has been accounted for under the accruals method.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR BIBDBLDBDGGB
Date   Source Headline
1st Apr 20267:00 amRNSDirectorate change
3rd Feb 20263:01 pmRNSRetirement of Director
26th Nov 202512:00 pmRNSHalf-year Report
11th Sep 20252:22 pmRNSResult of AGM
25th Jul 20258:35 amRNSFinal Results & Notice of AGM
4th Feb 20253:15 pmRNSChange of Auditor
26th Nov 20247:00 amRNSHalf-year Report
5th Sep 20244:38 pmRNSResult of AGM
7th Aug 20247:00 amRNSFinal Results
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.